Mats Holmberg

1.6k total citations
38 papers, 865 citations indexed

About

Mats Holmberg is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mats Holmberg has authored 38 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mats Holmberg's work include Thyroid Disorders and Treatments (9 papers), LGBTQ Health, Identity, and Policy (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Mats Holmberg is often cited by papers focused on Thyroid Disorders and Treatments (9 papers), LGBTQ Health, Identity, and Policy (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Mats Holmberg collaborates with scholars based in Sweden, Denmark and United States. Mats Holmberg's co-authors include Stefan Arver, Steinbjørn Hansen, Cecilia Dhejne, Morten Mau‐Sørensen, Hans Skovgaard Poulsen, Ulrik Lassen, Jesper Carl, Helle Broholm, Michael Kosteljanetz and Marie‐Thérése Stockhausen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, European Journal of Neuroscience and Journal of Internal Medicine.

In The Last Decade

Mats Holmberg

35 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mats Holmberg Sweden 15 210 193 190 150 127 38 865
Qing Mao China 17 393 1.9× 35 0.2× 77 0.4× 46 0.3× 95 0.7× 49 938
Geraldine Thomas United Kingdom 17 42 0.2× 452 2.3× 171 0.9× 53 0.4× 166 1.3× 33 1.4k
F. Albarel France 17 56 0.3× 570 3.0× 48 0.3× 226 1.5× 75 0.6× 51 1.3k
Benedetta Pettorini United Kingdom 23 616 2.9× 216 1.1× 155 0.8× 18 0.1× 72 0.6× 70 1.5k
E. Greco Italy 14 129 0.6× 60 0.3× 48 0.3× 37 0.2× 41 0.3× 44 849
Alice Chan United States 17 48 0.2× 95 0.5× 83 0.4× 20 0.1× 101 0.8× 42 1.1k
Sandra K. Johnston United States 19 553 2.6× 50 0.3× 239 1.3× 25 0.2× 148 1.2× 42 1.1k
Peter Manley United States 25 829 3.9× 136 0.7× 242 1.3× 16 0.1× 69 0.5× 77 2.1k
Marion Fournier France 15 54 0.3× 42 0.2× 76 0.4× 63 0.4× 27 0.2× 59 840
Judith Ford United States 19 271 1.3× 58 0.3× 366 1.9× 17 0.1× 99 0.8× 23 1.2k

Countries citing papers authored by Mats Holmberg

Since Specialization
Citations

This map shows the geographic impact of Mats Holmberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Holmberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Holmberg more than expected).

Fields of papers citing papers by Mats Holmberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Holmberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Holmberg. The network helps show where Mats Holmberg may publish in the future.

Co-authorship network of co-authors of Mats Holmberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Holmberg. A scholar is included among the top collaborators of Mats Holmberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Holmberg. Mats Holmberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subramanian, N, Anna Wiik, Eric Rullman, et al.. (2024). Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals. Journal of Endocrinological Investigation. 47(9). 2249–2260. 3 indexed citations
2.
3.
Holmberg, Mats, Helge Malmgren, Peter Berglund, Birgitta Johansson, & Helena Filipsson Nyström. (2024). Psychiatric complications in Graves’ disease. European Thyroid Journal. 13(1). 6 indexed citations
4.
Johansson, Birgitta, et al.. (2023). The relationship between mental fatigue, depression, and cognition in Graves’ disease. European Thyroid Journal. 12(4). 8 indexed citations
5.
Calissendorff, Jan, Per Karkov Cramon, Bengt Hallengren, et al.. (2023). Long-Term Outcome of Graves' Disease: A Gender Perspective. Women s Health Reports. 4(1). 487–496. 4 indexed citations
6.
Holmberg, Mats. (2023). Before We Were Trans. A New History of Gender. Journal of Sex & Marital Therapy. 49(2). 243–245. 14 indexed citations
7.
Sjölin, Gabriel, Torquil Watt, Jan Calissendorff, et al.. (2022). Long term outcome after toxic nodular goitre. Thyroid Research. 15(1). 20–20.
8.
Moody, Teena D., Jamie D. Feusner, Nicco Reggente, et al.. (2020). Predicting outcomes of cross-sex hormone therapy in transgender individuals with gender incongruence based on pre-therapy resting-state brain connectivity. NeuroImage Clinical. 29. 102517–102517. 14 indexed citations
9.
Kilpatrick, Lisa A., Mats Holmberg, Amirhossein Manzouri, & Ivanka Savic. (2019). Cross sex hormone treatment is linked with a reversal of cerebral patterns associated with gender dysphoria to the baseline of cisgender controls. European Journal of Neuroscience. 50(8). 3269–3281. 20 indexed citations
10.
Sjölin, Gabriel, Mats Holmberg, Ove Törring, et al.. (2019). The Long-Term Outcome of Treatment for Graves' Hyperthyroidism. Thyroid. 29(11). 1545–1557. 64 indexed citations
11.
12.
Holmberg, Mats, Helge Malmgren, Peter Berglund, et al.. (2019). Structural brain changes in hyperthyroid Graves’ disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden—the CogThy project. BMJ Open. 9(11). e031168–e031168. 7 indexed citations
13.
Wiik, Anna, Daniel P. Andersson, Torkel B. Brismar, et al.. (2018). Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study. Contemporary Clinical Trials Communications. 10. 148–153. 31 indexed citations
14.
Holmberg, Mats, Stefan Arver, & Cecilia Dhejne. (2018). Supporting sexuality and improving sexual function in transgender persons. Nature Reviews Urology. 16(2). 121–139. 78 indexed citations
15.
Holmberg, Mats, et al.. (2014). A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncologica. 53(10). 1321–1328. 31 indexed citations
16.
Holmberg, Mats, et al.. (2013). Differences in supratentorial white matter diffusion after radiotherapy – new biomarker of normal brain tissue damage?. Acta Oncologica. 52(7). 1314–1319. 28 indexed citations
17.
Langkilde, Niels Christian, et al.. (2013). MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncologica. 53(6). 809–814. 48 indexed citations
18.
Møller, Søren, Kirsten Grunnet, Steinbjørn Hansen, et al.. (2012). A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy. Acta Oncologica. 51(6). 797–804. 47 indexed citations
19.
Carl, Jesper, et al.. (2010). Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncologica. 50(4). 547–554. 8 indexed citations
20.
Carl, Jesper, et al.. (2008). A new fiducial marker for Image-guided radiotherapy of prostate cancer: Clinical experience. Acta Oncologica. 47(7). 1358–1366. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Mao Breakdown of academic impact, for papers by Geraldine Thomas Breakdown of academic impact, for papers by F. Albarel Breakdown of academic impact, for papers by Benedetta Pettorini Breakdown of academic impact, for papers by E. Greco Breakdown of academic impact, for papers by Alice Chan Breakdown of academic impact, for papers by Sandra K. Johnston Breakdown of academic impact, for papers by Peter Manley Breakdown of academic impact, for papers by Marion Fournier Breakdown of academic impact, for papers by Judith Ford
Rankless by CCL
2026